02/14/2026
Perimenopause is not simply a hormonal decline.
It is a ๐บ๐ฒ๐๐ฎ๐ฏ๐ผ๐น๐ถ๐ฐ ๐๐ฟ๐ฎ๐ป๐๐ถ๐๐ถ๐ผ๐ป.
Estrogen reduction alters insulin signaling, body composition, inflammatory tone, and mood resilience. Many women gain weight despite unchanged habits โ because their physiology is shifting.
Recent clinical data suggests that GLP-1 receptor agonists used alongside hormone replacement therapy may offer additive metabolic benefits โ not just appetite suppression.
When used strategically and at appropriate dosing, GLP-1 may support:
โข Insulin sensitivity
โข Visceral fat reduction
โข Muscle preservation
โข Mood stabilization
โข Cardiovascular health
โข Cognitive resilience
This is not factory dosing.
This is coordinated signaling support during a time of biological transition.
Menopause requires sophistication.
Not suppression.
โ๏ธ Interested in booking a free a Discovery Call with Dr. Angie? Visit https://p.bttr.to/3CNMr0c to schedule your call.
ยฉ Copyright 2026 RootCause Medicine. All Rights Reserved